Aminopeptidases and Angiogenesis

References

• Akada K., Yamazaki T., Miyashita H., Niizeki O., Abe M., Sato A., Satomi S., and Sato Y. (2002) Puromycin insensitive leucyl-specific aminopeptidase (PILSAP) is involved in the activation of endothelial integrins. Journal of Cellular Physiology, 193, 253–262.
   Google Scholar
• Bhagwat S.V., Lahdenranta J., Giordano R., Arap W., Pasqualini R., and Shapiro L.H. (2001) CD13/APN is activated by angiogenic signals and is essential for capillary tube formation. Blood, 97, 652–659.
   Google Scholar
• Bhagwat S.V., Petrovic N., Okamoto Y., and Shapiro L.H. (2003) The angiogenic regulator CD13/APN is a transcriptional target of Ras signaling pathways in endothelial morphogenesis. Blood, 101, 1818–1826.
   Google Scholar
• Cadel S., Pierotti A.R., Foulon T., Creminon C., Barre N., Segretain D., and Cohen P. (1995) Aminopeptidase-B in the rat testes: Isolation, functional properties and cellular localization in the seminiferous tubules. Molecular and Cellular Endocrinology, 110, 149–160.
   Google Scholar
• Constam D.B., Tobler A.R., Rensing-Ehl A., Kemler I., Hersh L.B., and Fontana A. (1995) Puromycin-sensitive aminopeptidase. Sequence analysis, expression, and functional characterization. Journal of Biological Chemistry, 270, 26931–26939.
   Google Scholar
• Cui X., Hawari F., Alsaaty S., Lawrence M., Combs C.A., Geng W., Rouhani F.N., Miskinis D., and Levine S.J. (2002) Identification of ARTS-1 as a novel TNFR1-binding protein that promotes TNFR1 ectodomain shedding. Journal of Clinical Investigation, 110, 515–526.
   Google Scholar
• Czekay G., and Bauer K. (1993) Identification of the thyrotropin-releasing-hormone-degrading ectoenzymeasametallopeptidase. Biochemistry Journal, 290, 921–926.
   Google Scholar
• Griffith E.C., Su Z., Niwayama S., Ramsay C.A., Chang Y.H., and Liu J.O. (1998) Molecular recognition of angiogenesis inhibitors fumagillin and ovalicin by methionine aminopeptidase 2. Proceedings of the National Academy of Science of the United States of America, 95, 15183–15188.
   Google Scholar
• Griffith E.C., Su Z., Turk B.E., Chen S., Chang Y.H., Wu Z., Biemann K., and Liu J.O. (1997) Methionine aminopeptidase (type 2) is the common target for angiogenesis inhibitors AGM-1470 and ovalicin. Chemistry and Biology, 4, 461–471.
   Google Scholar
• Hattori A., Matumoto H., Mizutani S., and Tsujimoto M. (1999) Characterization of recombinant human adipocyte-derived leucine aminopeptidase expressed in Chinese hamster ovary cells. Journal of Biochemistry, 125, 931–938.
   Google Scholar
• Ingber D., Fujita T., Kishimoto S., Sudo K., Kanamaru T., Brem H., and Folkman J. (1990) Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth. Nature, 348, 555–557.
   Google Scholar
• Keller S.R., Scott H.M., Mastic C.C., Aebersold R., and Lienhard G.E. (1995) Cloning and characterization of a novel insulin-regulated membrane aminopeptidase from Glut4 vesicles. Journal of Biological Chemistry, 270, 23612–23618.
   Google Scholar
• Kusaka M., Sudo K., Fujita T., Marui S., Itoh F., Ingber D., and FolkmanJ. (1991) Potent anti-angiogenic action of AGM-1470: Comparison to the fumagillin parent. Biochemical and Biophysical Research Communication, 174, 1070– 1076.
   Google Scholar
• Li X., and Chang Y.H. (1995) Amino-terminal protein processing in Saccharomyces cerevisiae is an essential function that requires two distinct methionine aminopeptidases. Proceedings of the National Academy of Science of the United States of America, 92, 12357–12361.
   Google Scholar
• Liu S., Widom J., Kemp C.W., Crews C.M., and Clardy J. (1998) Structure of human methionine aminopeptidase-2 complexed with fumagillin. Science, 282, 1324–1327.
   Google Scholar
• Look A.T., Ashmun R.A., Shapiro L.H., and Peiper S.C. (1989) Human myeloid plasma membrane glycoprotein CD13 (gp150) is identical to aminopeptidase N. Journal of Clinical Investigation, 83, 1299–1307.
   Google Scholar
• Lowther W.T., and Matthews B.W. (2000) Structure and function of the methionine aminopeptidases. Biochimca et Biophysca Acta, 1477, 157– 167.
   Google Scholar
• Lowther W.T., and Matthews B.W. (2002) Metalloaminopeptidases: Common functional themes in disparate structural surroundings. Chemical Reviews, 102, 4581–4608.
   Google Scholar
• Miyashita H., Yamazaki T., Akada T., Niizeki O., Ogawa M., Nishikawa S.-I., and Sato Y. (2002) A mouse orthologue of puromycin insensitive leucyl-specific aminopeptidase (PILSAP) is expressed in endothelial cells and plays an important role in angiogenesis. Blood, 99, 3241–3249.
   Google Scholar
• Ohishi N., Izumi T., Seyama Y., and Shimizu T. (1990) Purification and characterization of human lung leukotriene A4 hydrolase. Methods in Enzymology, 187, 286–295.
   Google Scholar
• Olsen J., Cowell G.M., Konigshofer E., Danielsen E.M., Moller J., Laustsen L., Hansen O.C., Welinder K.G., Engberg J., Hunziker W., Spiess M., Sjostrom H., and Noren O. (1988) Complete amino acid sequence of human intestinal aminopeptidase N as deduced from cloned cDNA. FEBS Letters, 238, 307–314.
   PubMed Web of Science ®Google Scholar
• Pasqualini R., Koivunen E., Kain R., Lahdenranta J., Sakamoto M., Stryhn A., Ashmun R.A., Shapiro L.H., Arap W., and Ruoslahti E. (2000) Aminopeptidase N is a receptor for tumor-homing peptides and a target for inhibiting angiogenesis. Cancer Research, 60,722–727.
   Google Scholar
• Rogi T., Tsujimoto M., Nakazato H., Mizutani S., and Tomoda Y. (1996) Human placental leucine aminopeptidase/oxytocinase. A new member of type II membrane-spanning zinc metallopeptidase family. Journal of Biological Chemistry, 271, 56–61.
   PubMed Web of Science ®Google Scholar
• Saiki I., Fujii H., Yoneda J., AbeF., NakajimaM., Tsuruo T., and AzumaI. (1993) Role of aminopeptidase N (CD13) in tumor-cell invasion and extracellular matrix degradation. International Journal of Cancer, 54, 137–143.
   PubMed Web of Science ®Google Scholar
• Schomburg L., Kollmus H., Friedrichsen S., and Bauer K. (2000) Molecular characterization of a puromycin-insensitive leucyl-specific aminopeptidase, PILS-AP. European Journal of Biochemistry, 267, 3198–3207.
   PubMedGoogle Scholar
• Serwold T., Gonzalez F., Kim J., Jacob R., and Shastri N. (2002) ERAAP customizes peptides for MHC class I molecules in the endoplasmic reticulum. Nature, 419, 480–483.
   Google Scholar
• Sin N., Meng L., Wang M.Q., Wen J.J., Bornmann W.G., and Crews CM. (1997) The anti-angiogenic agent fumagillin covalently binds and inhibits the methionine aminopeptidase, MetAP-2. Proceedings of the National Academy of Science of the United States of America, 94, 6099–6103.
   PubMed Web of Science ®Google Scholar
• Wang J., Lou P., and Henkin J. (2000) Selective inhibition of endothelial cell proliferation by fumagillin is not due to differential expression of methionine aminopeptidases. Journal of Cellular Biochemistry, 77, 465–473.
   PubMed Web of Science ®Google Scholar
• Wu Q., Lahti J.M., Air G.M., Burrows P.D., and Cooper M.D. (1990) Molecular cloning of the murine BP-1/6C3 antigen: A member of the zinc-dependent metallopeptidase family. Proceedings of the National Academy of Science of the United States of America, 87, 993–997.
   PubMed Web of Science ®Google Scholar